IDF Europe

💜🧠 On #WorldEpilepsyDay, we raise awareness of the close link between epilepsy and diabetes. Seizures can raise glucose levels, while glycaemic fluctuations may increase seizure risk. Strengthening understanding is key to better, person-centred care. 💙🤝

Member spotlight: in Jan 2026, Uzbekistan adopted the National Programme “Combating Heart Attack and Stroke”. ❤️🧠 IDF Europe member UMID supports this implementation by leading important community efforts. read more here: idf.org/europe/membe...

🔬New insights on optimising current screening for mild cognitive impairment (MCI) for PwD, out now! We're proud to have been a consortium member of the EU funded Recognised project, which has published a new study in @DiabetologiaJnl . 🔗Read here: link.springer.com/epdf/10.1007...

YouTube video by IDF Europe Webinar: Unlocking Horizon Europe – navigating opportunities for diabetes research

🎥 Watch recorded webinar now!

Recently, IDF Europe and Breakthrough T1D hosted a webinar on the Horizon Europe Work Programme 2026–2027, exploring new funding opportunities to advance diabetes research, care and innovation.
👉 Watch the recording here: www.youtube.com/watch?v=iNi1...

📬 Our January #newsletter is out!
📰 Read our editorial to learn about IDFEs direction and policy priorities in 2026
🌱 Look out for applications for the #YLL
💼 Stay up to date on diabetes research funding calls
Read the newsletter here for more: createsend.com/t/t-E3B111C4...

YouTube video by IDF Europe Interview with Eelco de Koning: ISLET PROJECT

🔬 The EU-funded ISLET Project is advancing cell-based therapies for type 1 diabetes. In this video, Prof. Eelco de Koning (LUMC) shares insights on translational research, islet transplantation, scalability and the role of PwT1D. ▶️ Watch now www.youtube.com/watch?v=berA...

WHO Executive Board, 158th session The 158th session of the WHO Executive Board take place on 2–7 February 2026.

The 158th WHO Executive Board opens in Geneva, shaping global health priorities including #UHC, #NCDs & mental health. DG Dr. Tedros highlights stability, focus & collaboration. Follow updates: www.who.int/about/govern...

🙌 Are you attending #ATTD2026? Don't miss our symposium: "From diabetes detection to cure: turning vision into reality".

We will explore how innovation and early intervention can improve outcomes for people living with, or at risk of, #diabetes.

👉 Read more: idf.org/europe/event...

Video Conferencing, Web Conferencing, Webinars, Screen Sharing Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom ...

📢 Join @WHO_Europe & JA PreventNCD on 10 Feb for a webinar on Front-of-Pack Labelling! Learn how it supports healthier diets through expert insights, country experiences & live Q&A. Open to participants across Europe & beyond. Register here: who.zoom.us/webinar/regi...

European Parliament event: “Addressing the growing prevalence of diabetes and obesity” - IDF Europe Site

🙏A big thank you to MEP Romana Jerković for hosting our EU Parliament event, and to all speakers and advocates for their powerful contributions and commitment to improving the lives of people living with #diabetes and #obesity.

➡️Read more: idf.org/europe/news/...

YouTube video by IDF Europe Interview with Henrik Semb: ISLET Project

🔍 From lab to clinic:
In this ISLET Project video, Henrik Semb, Scientific Leader of ISLET, reflects on the project’s vision, key breakthroughs, and the path to clinical translation, including challenges around scalability and access. ▶️ youtu.be/1ideWfsTCro

📣Survey closes today!
Breakthrough T1D and INNODIA are inviting people living with T1D, and their parents and caregivers, to take part in a survey to share their experiences with and perspectives on clinical trial participation.
forms.office.com/pages/respon...

📅 29 Jan | 10.00–12.00 CET , European Parliament. Join IDF Europe and MEP Romana Jerković for a policy dialogue on obesity & type 2 diabetes. Registration currently only open to those with EP accreditation docs.google.com/forms/d/e/1F...

YouTube video by IDF Europe Webinar: Unlocking Horizon Europe – navigating opportunities for diabetes research

IDF Europe and Breakthrough T1D recently hosted a webinar on the Horizon Europe Work Programme 2026–2027, exploring new funding opportunities to advance diabetes research, care and innovation. Missed it? Watch the recording here:
www.youtube.com/watch?v=iNi1...

YouTube video by IDF Europe Interview with Heiko Lickert: ISLET Project

🔬 How is research shaping the future of #T1D care? Prof. Heiko Lickert from the ISLET Project shares insights on cell-based therapies, his research focus, and where diabetes treatment could be in the next 10 years. ▶️ Watch: youtu.be/h1Z0YhwfDic

📣Two days left to take part in a survey on T1D! BreakthroughT1D and INNODIA invite people with T1D, parents, and caregivers to share their experiences with clinical trials. forms.office.com/pages/respon...

Our event is in three days! On 29 Jan from 10:00-12:00 CET, IDF Europe and MEP Romana Jerković are hosting a policy dialogue on obesity & T2D. Register here: docs.google.com/forms/d/e/1F...

YouTube video by IDF Europe Interview with Eelco de Koning: ISLET PROJECT

🔬The EU-funded ISLET Project is advancing cell-based therapies for #T1D. In this video, Prof. Eelco de Koning (LUMC) shares insights on translational research, islet transplantation, scalability & the role of people living with T1D.

▶️Watch now: www.youtube.com/watch?v=berA...

📖Interested in the history of diabetes? Explore more in our publication, "Readings on Diabetes": idf.org/europe/media...

🎉On Jan 23, 1922, 14-year-old Leonard Thompson became the first person to receive a successful insulin injection, marking a milestone in diabetes care and improving quality of life for PwD.

➡️Discover the history of insulin in our virtual exhibition: idf.org/europe/media...

📣 Take part in a T1D Survey!
@BreakthroughT1D
&
@Innodiagroup
are inviting people living T1D, as well as parents and carers to take part in a survey, sharing their perspectives on clinical trial participation.
🔗 forms.office.com/pages/respon...
Anonymous and only open until 29 Jan

📅 29 Jan | 10.00–12.00 CET
📍 European Parliament (Room 3H1), Brussels

Join IDF Europe and MEP Romana Jerković for a policy dialogue on obesity & type 2 diabetes. With 34M people in the EU living with diabetes, integrated, person-centred care is urgent.

🔗 Register: docs.google.com/forms/d/e/1F...

📢 Today, IDF Europe’s Sabine Dupont, joined a panel at the Irish Parliament on access to CGM devices for people living with diabetes. They discussed equity, education and expanding access to CGMs for everyone on insulin.
Access to technology is vital for self management.

🙌Don’t forget to apply to be the host of the IDF Europe 2026 Youth Leadership Lab!
⬇️Applications close on January 31.
(Please note: only IDF Europe Member Associations are eligible to apply.)
www.surveymonkey.com/r/Z8XXNZN

Advancing cell therapy for type 1 diabetes: interviews with ISLET project leaders - IDF Europe Site

The ISLET project is advancing cell therapy for type 1 diabetes by addressing a key challenge: replacing insulin-producing beta cells. In our new video series, ISLET researchers share insights on translation, challenges and future directions. idf.org/europe/news/...

📅 29 Jan | 10.00–12.00 CET 📍 European Parliament (Room 3H1), Brussels
Join us for a policy dialogue on obesity and type 2 diabetes (T2D) hosted by MEP Romana Jerković. Register here: docs.google.com/forms/d/e/1F...

📅 29 Jan | 10.00–12.00 CET
📍 European Parliament (Room 3H1), Brussels
Join us for a policy dialogue on obesity and type 2 diabetes (T2D) hosted by MEP Romana Jerkovik

🔗Register here: docs.google.com/forms/d/e/1F...

🙌 Curious about funding opportunities for #diabetes #research and #innovation in the EU? Join our webinar with Breakthrough T1D to explore the latest #HorizonEurope calls and discover ways to connect with potential collaborators.
📅 20 January 2026
🕐 13:00–14:00 CET

➡️ Sign up here: lnkd.in/e7ayknkv

Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement Insulin resistance increases after the first trimester of pregnancy, leading to glycaemic challenges for women with pregestational type 1 diabetes or …

🔎New publication outlining 14 evidence-informed recommendations on the use of continuous glucose monitoring ( #CGM ) & automated insulin delivery ( #AID ) technologies for pregnant women with #T1D, #T2D or gestational diabetes ( #GDM ).

➡️Read the publication: www.sciencedirect.com/science/arti...

📣 People living with #diabetes deserve accurate, reliable and safe #CGMs. Stronger EU standards are needed to ensure devices are truly fit for purpose.

➡️ Check out our document on the need to guarantee CGMs quality in Europe, now also available in Polish: idf.org/europe/news/...